Skip to main content
Signal8

FIELDS HEIDI

SEC insider (Form 3/4/5 filer). CIK 0001014330. Director at Phathom Pharmaceuticals, Inc. (PHAT) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in FLORHAM PARK, NJ.

Companies FIELDS HEIDI has filed insider reports for

  • Phathom Pharmaceuticals, Inc. (PHAT): Director
  • AGILENT TECHNOLOGIES, INC. (A): Director
FIELDS HEIDI profile photo

FIELDS HEIDI

CIK: 0001014330

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Phathom Pharmaceuticals, Inc. logo
PHAT

Phathom Pharmaceuticals, Inc.

Director
AGILENT TECHNOLOGIES, INC. logo
A

AGILENT TECHNOLOGIES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Phathom Pharmaceuticals, Inc. logo
    PHAT

    Phathom Pharmaceuticals, Inc.

    May 19, 2026
    Award
    Direct
    24.1K shares-
  • Phathom Pharmaceuticals, Inc. logo
    PHAT

    Phathom Pharmaceuticals, Inc.

    Jun 3, 2025
    Award
    Direct
    10.5K shares-
  • AGILENT TECHNOLOGIES, INC. logo
    A

    AGILENT TECHNOLOGIES, INC.

    Mar 14, 2025
    Award
    Indirect
    1.8K shares at avg. $121.18$220K

1-3 of 3